Home › Multiple Myeloma › Illinois › North Peoria
Multiple Myeloma clinical trials in North Peoria, IL
3 studies for Multiple Myeloma are looking for participants at sites in and around North Peoria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
RecruitingPhase 2
- Illinois CancerCare - Washington, Washington · 9 mi away
- Illinois CancerCare-Eureka, Eureka · 16 mi away
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RecruitingPhase 3
- Illinois CancerCare - Washington, Washington · 9 mi away
- Illinois CancerCare-Eureka, Eureka · 16 mi away
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RecruitingPhase 3
- Illinois CancerCare - Washington, Washington · 9 mi away
- Illinois CancerCare-Eureka, Eureka · 16 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in North Peoria
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer10 studies
- Colorectal Cancer7 studies
- Prostate Cancer6 studies
- Breast Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Acute Myeloid Leukemia4 studies
- Pancreatic Cancer4 studies
- Melanoma4 studies
- Colon Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.